NDC11 54436002004
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 54436-0020-04 | 54436-0020 |
| 54436-0020-4 | 54436-0020 |
| 54436-020-04 | 54436-020 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Otrexup | METHOTREXATE | Antares Pharma, Inc. | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 54436-020-04 54436-020 54436002004 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.